Vanda Pharmaceuticals to Announce First Quarter 2017 Financial Results on May 2, 2017

Friday, April 14, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

WASHINGTON, April 13, 2017 /PRNewswire/ --Conference Call and Webcast to Follow

Vanda Pharmaceuticals Inc. (Vanda)

(NASDAQ: VNDA) today announced it will release results for the first quarter of 2017 on Tuesday, May 2, 2017, after the market closes.

Vanda will host a conference call at 4:30 PM ET

on Tuesday, May 2, 2017, during which management will discuss the first quarter 2017 financial results and other corporate activities. To participate in the conference call, please dial 1-800-708-4539 (domestic) or 1-847-619-6396 (international) and use passcode 44748467.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Tuesday, May 2, 2017, beginning at 7:00 PM ET and will be accessible until Tuesday, May 9, 2017, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers. The passcode number is 44748467.

ABOUT VANDA PHARMACEUTICALS INC.:Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Investor Contact:Jim KellyExecutive Vice President & Chief Financial OfficerVanda Pharmaceuticals Inc.(202) [email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2017-financial-results-on-may-2-2017-300439682.html

SOURCE Vanda Pharmaceuticals Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook